Tags |
|
|
Links |
|
|
Advice You - Abandoning Bad Marketing Campaigns
When a business is engaged in a marketing campaign and it is obvious
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
things are not going correct it is often better to stop the marketi
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
g campaign immediately rather than to continue and try to evaluate a
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
d fix the problem gone bad.
Why you ask? Well simple really if you
Why you ask? Well simple really if you
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ontinue and you are confusing your customers, then you are diluting
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
our brand name and changing a perhaps longtime image in your custome
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
r’s mind and you can actually lose customers?
Additionally we have
Additionally we have
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ll heard the saying that you only get one chance to make a first imp
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ession, so if you screw it up those potential customers you attracte
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
will be turned off and those potential customers who heard about yo
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
r marketing campaign slogan or saw an ad may be convinced that it is
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
not what they thought it was or even what they would ever want. Whi
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
e had they never heard of the marketing campaign or saw an ad, they
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ay have eventually walked into the outlet out of curiosity you see?
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
o losing customers can be at stake and if you are a marketing profes
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ional and you see trouble, pull the plug and save the brand name.
T
T
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
he brand name capital is at risk and that is more important than you
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
job. Although I have often watched marketing executives keep trying
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
when something was not working and they ended up losing both anyway.
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
Their regional brand image and then their job. Consider this in 2006
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/27978/adviceyou-Abandoning-Bad-Marketing-Campaigns.html">Abandoning Bad Marketing Campaigns</a>
BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/27978/adviceyou-Abandoning-Bad-Marketing-Campaigns.html]Abandoning Bad Marketing Campaigns[/url]
Related Articles:
Letters of Credit - What You Need to Know
Bookmark it:
|